Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Gold may test $4,000 amid strong dollar, hawkish Fed: Mirae Asset ShareKhan
Gold price outlook: In the near term, gold can slide further. A test of support around $4000 is possible, while an extended decline to $3800 cannot be ruled out.
Cipla appoints health chief Shivam Puri to lead One India business
Cipla has appointed Shivam Puri as the new Chief Executive Officer for its One India Business. This significant leadership change will take effect from July 1. Puri currently heads Cipla Health, a role he has held since 2019. His extensive experience in consumer goods and healthcare will now steer Cipla's domestic operations.
Margin play: Why Supertails is doubling down on the lucrative pet healthcare market
With medical services yielding double the margins of retail, the startup is expanding its clinic and pharmacy footprint to anchor itself at the centre of India's formalizing pet economy.
INR recovers momentum as local equities rebound; recent oil and dollar spike fades amid signs of easing geopolitical tensions
The Indian rupee recovered momentum to settle higher by around 28 paise at Rs 95.31 per dollar on Tuesday, supported by retreating international oil prices and small pullback in dollar overseas. Meanwhile, local equities also rebounded from two-month lows as a halt in hostilities between Israel and Iran boosted hopes that peace negotiations could move forward. Geopolitical tensions eased somewhat, the dollar weakened and Brent crude futures fell below $93 a barrel as Israel and Iran agreed to halt attacks against each other following a series of mutual attacks from Sunday night, which marked the most serious escalation since the ceasefire in April. The BSE Sensex settled 394.50 points (0.54%) higher at 73,918.76, while the NSE Nifty 50 advanced 119.10 points (0.52%) to close at 23,242.10.
Haleon to invest Rs 2,000 crore to set up first India plant
Haleon is investing Rs 2,000 crore to build its first manufacturing plant in Pithampur, India. This move sharpens its focus on India, a fast-growing consumer healthcare market. The plant will produce oral-health products, including Sensodyne. It aims to reach one billion more consumers by 2030, with 300 million in India. The facility will also cater to export markets.
Retail holding tops FIIs in 118 Nifty 500 stocks since March 2024; who won?
In last two financial years, retail investors increased holding in 118 Nifty 500 stocks where FIIs cut stake; of these 65 stocks trade below March 2024 levels amid tepid market mood, shows data.
PE wars to billion-dollar IPO dreams, hospital sector is fighting fit
Major private equity firms are vying for a stake in Cloudnine, a leading maternity and paediatric care chain. This intense competition highlights strong investor confidence in India's healthcare sector. The industry is entering a new growth phase driven by increasing demand, a shortage of hospital beds, and a rise in specialized medical services.
ET Alpha Wealth Summit: A 12% return is a really good job in markets, says HSBC MF CEO Kailash Kulkarni
HSBC Mutual Fund CEO Kailash Kulkarni urged investors to keep return expectations realistic, saying a 12% annual return is a strong outcome in equity markets. Speaking at the ET Alpha Wealth Summit, he highlighted export-led manufacturing as a key long-term opportunity and said AI could empower retail investors through better access to information.
FPIs beat mutual funds by rupee returns despite $27 billion exodus
Despite record outflow of $27 bn or ₹2.4 trillion, foreign portfolio investors' totted a rupee return on assets of 7.7% against MFs' 4.4%, thanks to Nifty outperforming broader markets last year. In dollar terms though their returns lag those of MFs.
INR depreciates further to one-week low as oil stays elevated amid Middle East turmoil
The Indian rupee depreciated further in opening trades on Wednesday as oil prices stay elevated, driving fears of inflationary pressures in future. INR opened at Rs 95.43 per dollar and hit a low of 95.65 so far during the day. Yesterday, rupee fell 15 paise to close at 95.34 against the US dollar, as global crude oil prices jumped and the American currency remained firm amid massive safe-haven inflows. Significant foreign fund outflows also weighed on the investor sentiments. Local equities continue to stay strained in early trades with BSE Sensex trading at 73,866.45, down by 783.39 points and NSE Nifty 50 trading at 23,247.90, down by 235.65 points.
INR settles lower as global crude oil prices stay elevated amid Middle East turmoil
The Indian rupee depreciated 15 paise to close at 95.34 (provisional) against the US dollar on Tuesday, as global crude oil prices jumped and the American currency remained firm amid massive safe-haven inflows. Significant foreign fund outflows also weighed on the investor sentiments. At the interbank foreign exchange market, the rupee opened at 95.16 against the US dollar, then touched an intraday high of 95.03 and a low of 95.37. Indian shares closed higher on Tuesday, staging a rebound after four days of losses as investors assessed mixed signals over the status of U.S.-Iran peace talks and awaited upcoming RBI rate decision. The Nifty 50 gained 100.95 points (0.43%) to close at 23,483.55, while the Sensex rose 382.50 points (0.52%) to settle at 74,649.84.
PB Fintech sees Rs 665 crore block deal as founders pare stake; Goldman among other top funds buy
PB Fintech founders Yashish Dahiya and Alok Bansal sold 38 lakh shares worth Rs 665 crore in a block deal. The shares were purchased by various institutional investors, including Goldman Sachs and Tata Mutual Fund, following the company's recent performance.